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Care for Abnormal Pap Tests
KATHERINE S. EGGLESTON, M.S.P.H.,1 ANN L. COKER, Ph.D.,1
IRENE PRABHU DAS, M.P.H., Ph.D.,2 SUZANNE T. CORDRAY, M.P.H.,3
and KATHRYN J. LUCHOK, Ph.D.4
ABSTRACT
Objective: Approximately 4000 women annually will die from preventable and treatable cer-
vical cancer. Failure to adhere to follow-up recommendations after an abnormal Pap test can
lead to development of cervical cancer. This paper summarizes the body of literature on ad-
herence to follow-up after an abnormal Pap test in order to facilitate development of inter-
ventions to decrease morbidity and mortality due to cervical cancer.
Methods: We conducted a comprehensive search of published literature addressing risk fac-
tors for adherence or interventions to improve adherence following an abnormal Pap test as
the outcome. We included peer-reviewed original research conducted in the United States
from 1990 to 2005.
Results: Fourteen analytical and twelve experimental studies that met our criteria were re-
viewed. Lesion severity and health beliefs were consistently associated with adherence rates.
Communication interventions, including telephone reminders, counseling, and educational
sessions, increased follow-up compliance across intervention studies. Inconsistent evidence
for associations among race, income, and age were found.
Conclusions: Further research is needed to reinforce current studies addressing health be-
liefs and social support. Interventions that focus on the interplay among psychological, edu-
cational, and communication barriers are necessary. These interventions should be adapted
and applied across various racial/ethnic and socioeconomic groups to reach all women with
a high-risk profile for invasive cervical cancer.
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INTRODUCTION
WHEN CERVICAL CANCER IS DETECTED EARLY, thelikelihood of survival is almost 100% with
appropriate follow-up and treatment.1 Despite
the preventable and treatable nature of this can-
cer, the American Cancer Society (ACS) estimates
that almost 4000 women will have died from cer-
vical cancer in 2006 in the United States.2 A key
part of this discrepancy is failure to obtain fol-
low-up care after an abnormal Pap test. The Pap
test, which screens for precursor lesions to cer-
vical cancer, is one of the most used cancer
screening tools currently available; countrywide
estimates from the Behavioral Risk Factor Sur-
veillance System (BRFSS) in 2004 report that
78%–90% of women aged 18 years had a Pap
test within the preceding 3 years.3
Follow-up diagnostic examinations and, if
necessary, treatment are central to the effec-
tiveness of the Pap test in the prevention of in-
vasive cervical cancer.4 In a recent study of
long-term members of a comprehensive medical
care program, 13% of invasive cervical carcino-
mas were attributable to failure to follow up
with abnormal Pap test results.5 With the ma-
jority of women adhering to Pap test guidelines,
more research is needed to determine why wo-
men who receive an abnormal result are not
complying with necessary follow-up and treat-
ment schedules.
A large body of literature suggests multiple
factors are associated with adherence to follow-
up recommendations, including factors associ-
ated with the patient, both demographic and psy-
chosocial in nature, and with the healthcare
system.6–9
The purpose of this systematic review is to
summarize reports from recent analytical or
experimental research that addressed factors as-
sociated with the lack of adequate and timely fol-
low-up care for an abnormal Pap test (nonadher-
ence). The future aim is to facilitate both patient
and clinic-based interventions to improve adher-
ence to follow-up recommendations and, thus, re-
duce needless deaths due to cervical cancer. This
is the first review to include both analytical and
intervention studies addressing adherence to ab-
normal Pap test follow-up recommendations and
to address risk factors for lack of follow-up by
individual, psychosocial, and attributes of the
healthcare system.
MATERIALS AND METHODS
A systematic approach to all literature was
used to identify original research addressing fol-
low-up of an abnormal Pap test. Our review in-
cluded academic peer-reviewed sources from the
following databases: Medline, Pubmed, Science
Direct, Medline-Ovid, Med Science, and Ebsco-
Medline. The search terms used were: abnormal
Pap, colposcopy, Pap test, screening, gynecolo-
gist, or cervical cancer, adherence, follow-up, bar-
riers. Reference lists from papers identified were
also reviewed for inclusion of additional papers.
To develop a comprehensive review, we in-
cluded papers published from 1990 to 2005 re-
gardless of whether they had been included in
past reviews. The outcome of interest for all pa-
pers reviewed was adherence to recommended
follow-up care for an abnormal Pap test. In ad-
dition, all papers included in the review had to
address risk factors for adherence or involve in-
terventions to improve adherence. A total of 73
abstracts were originally identified. Table 1 out-
lines the criteria for inclusion in this systematic
review and the numbers excluded based on
these criteria. We required that each study be
evidence based, in that the research involved
following women either prospectively or retro-
spectively through follow-up care after an ab-
normal Pap test (11 excluded). Studies con-
ducted outside the United States were excluded
because different systems of medical care are
not comparable to that of the United States (n 
12). Papers not published in English were also
excluded (n  7). Finally, qualitative research
(n  4), recent reviews (n  5), and literature
older than 1990 (n  8) were also excluded from
this review.
EGGLESTON ET AL.312
TABLE 1. SELECTION OF PAPERS INCLUDED
IN SYSTEMATIC REVIEW
Inclusion criteria Number excluded
Total studies originally identified 73
Evidenced based 11




Published since 1990 8
Total studies reviewed 26
Hosted in the Center for Research on Violence Against Women institutional repository with written permission from Mary Ann Liebert, publishers.
Defining abnormal Pap tests
For the purposes of this review, an abnormal
Pap test includes any result that requires addi-
tional diagnostic or follow-up procedures. There-
fore, the following Pap test results were consid-
ered abnormal: insufficient Pap test, infection,
atypia, atypical squamous cells of undetermined
significance (ASCUS), low-grade squamous in-
traepithelial lesions (LSIL), high-grade squamous
intraepithelial lesion (HSIL), and atypical glan-
dular cells (AGC).
Defining adherence
In this review, definitions of adherence varied
across studies, but all were evaluated based on
follow-up after an abnormal Pap test result
within a time period specified by each healthcare
office or governing organization.
RESULTS
Twenty-six papers were identified that met our
criteria.10–35 All studies were quantitative, de-
fined here as a study analyzing data using statis-
tics that reported a p value for correlations and
predictors. Table 2 summarizes the key design
elements of the 26 quantitative papers that
addressed adherence for abnormal Pap test fol-
low-up. The studies are arranged alphabetically
by the first author’s last name and are presented
in two groups by the study design (analytical 
and experimental studies). Fourteen papers 
used an analytical study design and addressed
risk factors for adherence.10–14,18–20,23,27–29,31,34
Twelve studies used an experimental or quasi-
experimental design: 9 were randomized tri-
als16,17,24–26,30,32,33,35 and 3 were intervention
studies based on nonrandomized designs.15,21,22
Table 2 provides the study setting and sample,
the number of subjects, the data source and list
of independent variables assessed, and the data
source and operational definition of the outcome
(adherence to follow-up recommendations for an
abnormal Pap test).
Study sites included public health and commu-
nity clinics,11,14,18,19,27–29 hospitals,13,31 academic
clinics,12,23,34 the National Breast and Cervical
Cancer Early Detection Program (NBCCEDP),10
and a large consortium of laboratories.20 The sam-
ple sizes ranged from 11923 to 16,132 women.20
With the exception of four studies that relied on
self-report through telephone interviews and
questionnaires,15,27,30,31 all used medical records
to obtain data on independent variables. All stud-
ies addressed demographic factors as indepen-
dent variables correlated with adherence; among
these were age, race/ethnicity, insurance, marital
status, education, income, place of residence, pri-
mary language spoken, tobacco use, and cervical
lesion severity. 
The reviewed research used medical records or
self-report to determine adherence and defined
adherence as the receipt of recommended follow-
up care. However, studies differed in the def-
inition of adherence. Most studies used a re-
stricted time frame10–12,15,16,18,20,21,23,26,28–30,34,35
that ranged from receipt of follow-up care within
4–6 weeks35 to receipt of follow up care within 
18 months.16 Other studies measured adher-
ence by the number of follow-up appointments
kept,14 ever completing the recommended proce-
dure,19,22,24,25,27,31 or adherence within the time
frame set by the physician.32,33
Table 3 lists the measures of association, a sum-
mary of the study findings, and adherence rates.
Adherence rates for the analytical studies ranged
from 27%28 to 90%,19 whereas those of the ex-
perimental studies ranged from 40%21 to 93%15
for those receiving the intervention. Nine of
twelve intervention studies15–17,24–26,30,32,35 re-
ported higher adherence among those participat-
ing in the intervention. The findings are summa-
rized by patient, healthcare system, and social/
environmental characteristics.
Patient characteristics
Age. Of the 14 studies10,11,14,16–18,20,23–27,31,34
that addressed age and adherence, 7 found that
younger women were less likely to receive fol-
low-up care.16,17,20,25–27,34 Specifically, McKee et
al.27 reported that teenagers and women older
than 30 were less likely to receive follow-up care.
Additionally, a study conducted by Fox et al.18
reported that increased age was a significant risk
factor for noncompliance. 
Race/ethnicity. Of the 10 analytical10–12,14,18,23,27,28,31,34
and 7 experimental16,17,24–26,30,32 studies to address
race/ethnicity and adherence, 710,11,17,18,25,26,32 found
that African American women were less likely to
schedule follow-up visits, to keep appointments,
BARRIERS TO FOLLOW-UP FOR ABNORMAL PAP TESTS 313


































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Hosted in the Center for Research on Violence Against Women institutional repository with written permission from Mary Ann Liebert, publishers.
or to receive follow-up care. Specifically, Cardin
et al.11 reported that African American women
with ASCUS/LSIL were less likely to be compli-
ant than African American women with HSIL.
Four studies12,16–18 reported that Asian women
were less likely than women of other race/eth-
nicities (whites or African Americans) to comply
with follow-up recommendations. Finally, two
studies found that Hispanics were significantly
less likely to adhere to follow-up recommenda-
tions than white18 and African American wo-
men.25 However, the only study to address fatal-
ism and health beliefs,31 reported that race/
ethnicity was no longer associated with adher-
ence after adjusting for these factors.
Primary language. All three studies that inves-
tigated a primary language other than English as
a barrier to follow-up care17,29,34 concluded that
this demographic was not associated with ad-
herence.
Place of residence. Two studies examined place of
residence by assessing urban vs. rural residence18
and proximity to clinic.29 Proximity to clinic was
not a predictor of adherence,29 but urban setting
was a significant predictor of nonadherence.18
Education. Five studies investigated educa-
tional attainment, measured by receipt of a high
school diploma,24,25,27,30,31 as a predictor of ad-
herence to follow-up care. Only one study found
that those with less than a high school education
were less likely to return for follow-up care.25
Pregnancy status. Three studies addressed preg-
nancy status and adherence17,20,28; only and No-
vis20 reported that pregnant women were less
likely to receive timely follow-up. Gravidity and
parity were not associated with adherence in one
study,14 although being nulliparous was positively
associated with being adherent in another.32
Tobacco use. Two studies that assessed tobacco
use as a predictor of adherence to follow-up found
conflicting results. Eger and Peipert14 found that
tobacco use was not associated with the number of
follow-up appointments kept, whereas, Paskett et
al.32 found that nonsmokers were more likely than
smokers to follow up within 1 week of the date
specified by the physician.
Income/insurance/cost of follow-up. Thirteen studies
addressed income,14,19,31 insurance,14,16,17,23,25–29,34
or cost as barriers to receiving follow-up
care.21,25,26 Four found that those with higher in-
come19 or private insurance25,29,34 were more
likely to adhere to recommended follow-up. Con-
versely, Engelstad et al.16 found that women with
no insurance were more likely to have a follow-
up visit in 6 months than those with insurance.
The remaining eight studies found no association
between adherence and income14,21,31 or insur-
ance.14,17,23,26–28 Of three interventions21,25,26 to
address economic strain, however, two reported
that transportation incentives25 and economic
vouchers had a significant impact on adherence.26
Furthermore, cost, transportation, and child care
problems were among the most frequent barriers
reported by others.15,24,30
Knowledge of Pap test. Several studies addressed
the influence of Pap test knowledge on adherence
to follow-up.13,15,17,24–26,30–33 Both Crane13 and Nel-
son et al.31 found that women who did not know
the purpose of a Pap test were less likely to adhere
to recommendations than those who correctly
identified the purpose. Two studies that investi-
gated barriers to care reported that lack of under-
standing of the purpose of a follow-up examina-
tion was a reason for nonadherence.15,24 Studies
that used educational brochures26,32,33 or a tape on
Pap tests25 all reported a significant increase in
compliance. Telephone counseling interventions,
including education on abnormal Pap tests and the
importance of follow-up, also predicted adher-
ence.15,17,24,30 Finally, Lavin et al.23 found that a visit
to an adolescent clinic positively predicted adher-
ence; the authors speculated that during this visit,
more information on the purpose and importance
of follow-up care may have been given.
Lesion severity. Of the 15 studies that addressed lesion
severity and adherence,10,11,14,16–18,20,23,25–29,32,34
1110,11,14,16–18,20,25,26,28,29,32 found that women with less
severe lesions were less likely to adhere to follow-
up recommendations. Melnikow et al.29 reported
that, overall, women with LSIL/HSIL were more
likely to adhere to any appointment compared with
women with ASCUS; however, women with
LSIL/HSIL were less likely to adhere to colposcopy
compared with repeat Pap tests, whereas women
with ASCUS were more likely to adhere to col-
poscopy compared with repeat Pap tests. When fol-
lowing women after two abnormal Pap tests, Be-
nard et al.10 stated that women whose results were
less severe on the second assessment were least
likely to receive the recommended colposcopy.
EGGLESTON ET AL.322
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Psychosocial factors
Psychological barriers. When addressing health be-
liefs and adherence, Nelson et al.31 found that fa-
talism and health beliefs (specifically, that Pap tests
were needed only when one had abnormal bleed-
ing) were associated with poor adherence. Another
study addressed psychological factors, including
fear of cancer, embarrassment of pelvic examina-
tions, and belief in early detection and follow-up.
Researchers reported no significant differences in
adherence among women who differed in re-
sponses on these items.27 Four intervention studies
used a case management approach to address psy-
chosocial factors, including attitudes, coping skills,
anxiety, and fear resulting from an abnormal Pap
test result.15,17,24,30 Psychological barriers to care re-
ported by women in each study included fear of
finding cancer, worries about examination/treat-
ment, and fertility concerns. All interventions ad-
dressing these concerns resulted in significant dif-
ferences in adherence; women in the intervention
group in each respective study were more than
twice as likely to follow up as women in the con-
trol group.15,17,24,30
Social support. Six studies addressed social sup-
port and marital status or live-in relationship as
a predictor of adherence to follow-up after an ab-
normal Pap test.13,14,24–26,30 Two found that wo-
men with a live-in relationship26 or those with
any type of social support13 were more likely to
follow up within 4–6 months than those without
a live-in relationship or any kind of social sup-
port. Crane.13 found that the type of support most
likely to affect adherence differed by ethnic
group. African American women were more
likely to adhere when emotional support was
available, whereas tangible support significantly
influenced adherence among Latinas.13
Healthcare system characteristics
A number of studies assessed the relationship
of adherence to existing clinician and site char-
acteristics, including appointment reminder pro-
tocols.15–17,19–22,26–28,30,34,35
Patient involvement/communication. Clinician in-
volvement of patients in decisions, referrals, and
management options were assessed in two stud-
ies.19,28 Hartz and Fenaughty19 reported that pa-
tients who chose surveillance had improved ini-
tial adherence but not long-term adherence.
McKee et al.28 reported that discussion of follow-
up options and plans at a prior visit increased ad-
herence rates. Communication between clinicians
and patients was also noted as a factor influenc-
ing adherence to follow-up. Lack of effective com-
munication was associated with lower rates of ad-
herence in one study,27 as both “knowledge of
results” and “getting the doctor to understand
my needs” were significantly associated with ad-
herence in univariate analysis.
Healthcare facility/clinician specialty. Site attrib-
utes were also assessed as an indicator of adher-
ence to follow-up in some studies. McKee et al.28
reported that clinics with colposcopy on-site had
higher adherence rates. Takacs et al.35 reported
that patients randomized to the video colposcopy
were five times more likely to return for follow-
up care relative to those receiving traditional col-
poscopy. Lacey et al.22 reported no difference in
follow-up rates between women who were re-
ferred to the public hospital and those who chose
to follow up with their private physician. Fur-
thermore, three studies27,28,34 found that clinician
specialty was not associated with improved ad-
herence. The only study to address laboratory
characteristics20 reported no association between
adherence and the type of follow-up system used
by clinics, laboratory reporting summaries, or the
proficiency of cytologists in reading slides.
Reminder protocols. Several experimental stud-
ies included protocols in which the healthcare fa-
cility called or sent a reminder letter approxi-
mately 1 week before the woman’s appointment
for follow-up care.15–17,21,26,30 Five15–17,26,30 of six
studies reported a positive association between
the reminder protocol and adherence to follow-
up care; three of the studies were coupled with
telephone counseling or an educational pam-
phlet.15,17,26 Miller et al.30 reported that the tele-
phone reminder system was effective at increas-
ing adherence rates, but not as effective as
additional telephone counseling. The only study
to report no change in adherence used a letter in-
stead of a telephone reminder system.21
Strengths and limitations of reviewed research
Table 4 outlines the strength and quality of
studies reviewed and provides a corresponding
score based on the following categories: power/
sample size, use of a theoretical model, study de-
sign, response rate, outcome validation, and mea-
surement of lesion severity. Studies that used a
BARRIERS TO FOLLOW-UP FOR ABNORMAL PAP TESTS 323
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retrospective cohort design were not considered
when assessing response rates.10–12,14,18,20,23,28,29,34
Therefore, the total score was out of 14 points for
those with a response rate and 12 points for those
without a response rate. Studies that scored
within the top third of the sample were deter-
mined to be of high quality (score  0.67) (Table
4).10,11,17,18,20,21,25,26,30–32
Sample size indicates study power and the abil-
ity to correctly rule out the possibility that a type
2 error occurred (not having sufficient power to
detect a true association). Study power is, how-
ever, a function of sample size, the prevalence of
the independent variable, and the prevalence 
of the outcome in the study population. Among
the reviewed research, nine had good study
power.10,11,18,20,21,25,26,30,31
The randomized trial design was a strength 
for nine studies.16,17,24–26,30,32,33,35 Eleven stud-
ies used a theoretical model to guide their research,
which was considered a strength.13,15,17,21,22,25,27,30–33
Only one study reported a low response rate
(35%),15 which may indicate questionable valid-
ity of the study results.
Misclassification of both the independent and
outcome variables can be a concern for obser-
vational studies and may lead to information
bias. Studies that relied exclusively on medi-
cal records for information on patient character-
istics10–12,14,16,18–25,28–35 may have misclassified
these variables if they are not routinely available
in medical records. Further, women who received
follow-up care at other clinics may have been
misidentified as nonadherent if self-reported fol-
low-up was not available. Four studies obtained
adherence information through self-report in ad-
dition to medical record abstraction; these stud-
ies both validated their outcomes using another
source and were able to obtain complete docu-
mentation from other sites.13,15,26,27 Another
study17 excluded women who reported follow-
up at another clinic to avoid this bias.
Because lesion severity may directly impact the
importance of and timeliness of adherence, we in-
cluded assessment by lesion severity as a com-
ponent of quality. Fourteen of 26 studies either
conducted separate analysis by lesion severity or
included only one type of lesion in their re-
search.10,11,15–21,25,26,28,29,32
As previously noted, having a range of adher-
ence definitions makes comparisons across the
studies challenging. In general, those studies with
shorter time intervals for defining adherence may
be more prone to outcome misclassification.
However, different types of noncompliance exist
(e.g., delay in seeking care, nonparticipation in
care, and cancellation of appointments), so all
may be considered an appropriate measure.
Summary of reviewed research
Table 5 provides a summary of factors ad-
dressed by the literature included in this system-
atic review. Table 5 provides a breakdown of the
associations by patient factors, psychosocial fac-
tors, and healthcare system factors. The strength
of association corresponds to the range of point
estimates (odds ratio [OR]/hazards ratio [HR])
for studies reporting a statistically significant as-
sociation (Weak, OR/HR: 1.0-1.49 or 0.68-1.0;
moderate, OR/HR: 1.5-3.0 or 0.33-0.67; strong,
OR/HR: 3.0-10.0 or 0.10-0.32). Furthermore,
Table 5 indicates the number of high-quality
studies that contributed to the results.
DISCUSSION
Over the past 15 years, many factors have been
hypothesized to affect adherence to follow-up
procedures following an abnormal Pap test. In
this discussion, we focus on modifiable risk fac-
tors for adherence at the patient, psychosocial,
and healthcare system levels and address future
directions for research.
Patient factors
Among those modifiable factors associated
with the patient, the majority of studies included
in this review agreed that women with less se-
vere lesions were less likely to be adherent to fol-
low-up care.10,11,14,16,18,20,25,26,28,29,32 Reasons for
this association may include a belief of both wo-
men and clinicians that follow-up is less impor-
tant for less severe Pap test results. Although this
may in general be true, all women recommended
for follow-up should receive follow-up care in a
timely manner, as some less severe lesions may
become more severe without follow-up. Potential
interventions may include stressing the impor-
tance of follow-up regardless of lesion severity
during patient-provider meetings and within ed-
ucational materials addressing abnormal Pap
tests.
The Pap test can detect lesions that will never
progress to cervical cancer; therefore, women
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who have an abnormal Pap test result of ASCUS
are now routinely tested for human papillo-
mavirus (HPV). Because most cervical cancer
cases result from persistent HPV infection, proper
education and counseling of the potential impact
of a positive HPV result may motivate women to
adhere to follow-up care in a timely manner.
Many women have noted lack of time, money,
or insurance as barriers to receiving timely fol-
low-up care.8,15 Although the majority of studies
found no association between economic factors
and adherence,14,17,21,23,26–28,31 transportation in-
centives and economic vouchers did significantly
increase adherence.25,26 Currently, the Breast and
Cervical Cancer Treatment Act provides medical
assistance through Medicaid to eligible women
who were screened for and found to have breast
or cervical cancer, including precancerous condi-
tions. However, women who are ineligible for
this service still may feel they cannot afford fol-
low-up care; these women may benefit from tar-
geted interventions to address economic barriers
to follow-up care.
Misunderstanding of the purpose of a Pap test
and the need for follow-up after an abnormal re-
sult were frequent barriers to care.13,15,24,31 All
interventions that addressed knowledge of the
Pap test and cervical cancer significantly in-
creased adherence rates.15,17,24–26,30,32,33 The cur-
rent knowledge gap can be addressed on a per-
sonal level by nurses, community health workers,
and patient navigators tailoring informational
needs to each woman. Furthermore, a need
clearly exists for a comprehensive, easy to un-
derstand, and culturally acceptable brochure to
aid in the education of women who have an ab-
normal Pap test.
Psychosocial factors
Social factors, such as the ability to cope effec-
tively with an abnormal result,30 as well as other
attitudinal beliefs that may be influenced by so-
cial support36 or culture may be important and
potentially modifiable risk factors for nonadher-
ence. To illustrate, greater fatalism was associated
with lower adherence rates in two studies re-
viewed;15,31 further, fatalism appears to be a
mediator in the association between race and ad-
herence and, unlike race, is potentially modifi-
able.31 The literature supports that the emotional
reaction (e.g., fear, anxiety, and depression) to the
news of an abnormal Pap test result may reduce
a woman’s ability to return for follow-up care in
a timely manner.8,15,17,24,30,31,37–39 A small litera-
ture suggests that stressful events occurring in
women’s lives around the time of the abnormal
Pap test may serve as competing life priorities,
thereby reducing the likelihood of obtaining fol-
low-up care.40–42 Effective coping strategies to re-
duce psychological distress from an abnormal
Pap result have been noted.13,43 In order to re-
duce clinic no-show rates, we need a better un-
derstanding of the interactions among anxiety,
distress, effective coping, and support as they af-
fect adherence.
Healthcare system characteristics
Although patients are ultimately responsible
for following the recommendations of their clin-
icians, clear patient-provider or laboratory com-
munications may have a positive impact on ad-
herence. Enhanced communication between the
patient and the provider in experimental studies
included in this review resulted in increased ad-
herence rates.16,17,24,25,30,32,33 Interventions aimed
at reducing this communication barrier included
telephone reminder systems, counseling/educa-
tional sessions, and instructive and culturally rel-
evant pamphlets. The success of these interven-
tions is consistent with studies reviewed by
Yabroff et al.4 and Abercrobmie.7 These inter-
ventions may differentially affect women across
a range of socioeconomic levels, and were tai-
lored to meet women’s individual needs.
Little research has addressed individual char-
acteristics of the provider in influencing the ef-
fectiveness of communication. Future directions
for research could include elements of effective
patient-provider communication. These may in-
clude observational studies with permissible
videotaped interactions. The type of healthcare
provider may vary (e.g., physician, nurse, health
education counselor), but the ability of the pro-
vider to simply and effectively communicate
medical information as well as personal concern
for that patient would be an important contribu-
tion.
CONCLUSIONS
Inconsistent evidence for risk factors and bar-
riers to receipt of follow-up care as well as ex-
treme differences in reported adherence rates
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across the 26 scholarly papers reviewed indicate
that the influence of demographic, individual,
and healthcare system level factors on adherence
to abnormal Pap tests is undoubtedly complex.
Women differ in their knowledge of cervical can-
cer screening, their attitudes toward preventive
follow-up care, and their overall access to this
care, including financial and transportation bar-
riers. Similarly, healthcare providers differ in
their attitudes and communication skills. The
healthcare system may determine follow-up
availability on site and extended clinic hours.
Future directions
A range of barriers for adherence to follow-up
after an abnormal Pap test have been identified in
the existing literature. Therefore, the most cost-ef-
fective strategy to overcome diverse barriers
among at-risk populations will likely include tai-
lored interventions through case management or
patient navigation. Additionally, although many
modalities of patient education are used (e.g., let-
ter, pamphlets, videotape/DVD, phone calls, e-
mails, websites), little research has addressed the
content of the material in terms of the intended au-
dience, the cultural competence for a range of au-
diences, or the accuracy in light of new HPV test-
ing methods, screening, and follow-up options.
Successful interventions, if incorporated into
everyday practice, may increase the short-term
cost of healthcare services. A recent study by
Wagner et al.44 however, suggests that tailored
counseling interventions may be more cost-effec-
tive than usual care among high-risk popula-
tions.44 By reducing barriers to follow-up care for
abnormal Pap tests, the financial cost of late-stage
treatment for cervical cancer will decrease. Fur-
ther, decreases in the adverse physical, psycho-
logical, and emotional effects of cervical cancer
morbidity and mortality would be significant.
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